A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote^*
* The abstract has been presented at North American Congress of Clinical toxicology (NACCT) 2016.

Tharwat El ZahranDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA; Correspondence[email protected]

Roy GeronaClinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, CA, USA

Brent W. MorganDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA;

Adam C. PomerleauDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA;

References

Yetter O. Identification of the synthetic cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H indazole-3-carboxamide (CUMYL-4CN-BINACA) in plant material and quantification in post-mortem blood samples. J Analyt Toxiocl. 2017;41:720–728.
PubMed Web of Science ®Google Scholar
Åstrand A, Vikingsson S, Lindstedt D, et al. Metabolism study for CUMYL-4CN-BINACA in human hepatocytes and authentic urine specimens: free cyanide is formed during the main metabolic pathway. Drug Test Anal. 2018;10:1270–1279. doi: 10.1002/dta.2373
PubMed Web of Science ®Google Scholar
Horth RZ, Crouch B, Horowitz BZ, et al. Notes from the field: acute poisonings from a synthetic cannabinoid sold as cannabidiol – Utah, 2017–2018. Morb Mortal Wkly Rep. 2018;67:587–588.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote^*
* The abstract has been presented at North American Congress of Clinical toxicology (NACCT) 2016.

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote** The abstract has been presented at North American Congress of Clinical toxicology (NACCT) 2016.

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote^*
* The abstract has been presented at North American Congress of Clinical toxicology (NACCT) 2016.